Abstract| Volume 43, ISSUE 12, P2385, December 2017

Optimised intraoperative parathyroid hormone (PTH) assay for shortening the duration of parathyroid surgery

      Introduction: Parathyroid surgery for primary hyperparathyroidism is challenging when preoperative investigations fail to localise the parathyroid adenoma. New methodology enables faster intraoperative parathyroid hormone (PTH) assessment, to support decision-making during surgery. We optimised a PTH assay by reducing antibody incubation times, with the aim of decreasing the delay during parathyroid operations whilst waiting for intraoperative PTH results, thus providing shorter and safer procedures for patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Surgical Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect